camzyos
(mavacamten)Myokardia, Inc.
Usage: CAMZYOS® is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to enhance functional capacity and alleviate symptoms.